Loading clinical trials...
Loading clinical trials...
Randomized Trial of Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients Who Have Undergone Lamivudine/Adefovir Add-on Treatment
Conditions
Interventions
Tenofovir disoproxil fumarate
Lamivudine plus adefovir
Locations
1
Taiwan
Taipei Veterans General Hospital-Division of Gastroenterology
Taipei, Taiwan
Start Date
September 1, 2012
Primary Completion Date
December 1, 2019
Completion Date
December 1, 2019
Last Updated
April 1, 2016
NCT06671093
NCT06885710
NCT06263959
NCT06295328
NCT02883647
NCT04139850
Lead Sponsor
Taipei Veterans General Hospital, Taiwan
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions